Skip to content

Anti-c (RH4) 210528

by Diagast

Anti-c (RH4) 210528 is an anti-C [RH004] red blood cell grouping IVD made by Diagast, listed in FDA GUDID since 1 May 2018 (UDI-DI 23661562105285), registry data as of 23 Oct 2026.

Listed FDA GUDID listing, no authorization on record

Valid until

Not applicable

Database listing, no authorization

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None

No authorization documents

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number23661562105285 UDI-DI Date1 May 2018ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

Device description
Blood Grouping Reagent, Anti-c (Human/Murine Monoclonal) (951) - This reagent is designed to determine the presence of the blood group antigen c (Rh4) on the surface of human red blood cells by manual tube method.
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
Labelled as containing natural rubber latex
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 23 Oct 2026, as the labeller entered it.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — GUDID listing Listed

Specification

GUDID

Trade name
Anti-c (RH4)
Generic name
Anti-C [RH004] red blood cell grouping IVD, antibody
Model / Ref / Catalog
210528
Primary DI / UDI-DI
23661562105285
GMDN term
Anti-C [RH004] red blood cell grouping IVD, antibody
GUDID distribution status
In Commercial Distribution

Other devices from Diagast

See all devices from Diagast →

Properties

  • Contains latex
  • Lot / batch number
  • Serial number
  • Expiration date
Other properties (10, all answered No)